Lakrimont

Carbomer 980, the active ingredient in Lakrimont, is a polymeric viscosity enhancer presented as an ophthalmic solution for ocular use. It is employed to provide lubrication and moisture retention on the ocular surface, helping to alleviate discomfort associated with dry eye conditions.

GNH USA supplies Lakrimont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lakrimont is a carbomer‑based ophthalmic solution that addresses ocular surface dryness and irritation.

- Dry eye syndrome: provides lubrication and prolongs tear film stability to relieve dryness and burning. - Post‑operative ocular care: helps maintain corneal moisture after eye surgery, supporting healing. - Contact lens discomfort: reduces friction and improves comfort for lens wearers. - Ocular surface protection: creates a protective gel layer that shields the epithelium from environmental stress.

Lakrimont may cause ocular irritation in some users.

Common Side Effects: - Transient blurred vision: temporary visual disturbance after instillation. - Mild stinging or burning: brief sensation upon drop application. - Redness of the eye: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit or sand. - Eye irritation: mild discomfort or itching.

Serious or Rare Side Effects: - Allergic reaction: swelling, rash, or hives around the eye. - Severe eye pain: persistent discomfort requiring medical review. - Vision loss: sudden decrease in visual acuity. - Corneal ulceration: ulcer formation on the cornea. - Ocular infection: signs of bacterial or fungal infection. - Persistent inflammation: prolonged redness or swelling.

Before using Lakrimont, consider the following safety measures.

- Assess ocular health: ensure the eye is free of infection or active inflammation. - Hypersensitivity: avoid if the patient has known allergy to carbomer or formulation excipients. - Solution integrity: do not use if the product appears discolored or contains particles. - Contact lens wearers: remove lenses before instillation and wait several minutes before reinserting. - Frequency limits: do not exceed the prescribed number of drops per day. - Store at room temperature: keep in the original container, protect from light and moisture.

Lakrimont may interact with other ophthalmic agents.

Major Interactions (Avoid): - Concurrent use with other viscous eye drops: can cause precipitation or reduced efficacy. - Use with ophthalmic antibiotics containing preservatives: may increase ocular irritation.

Moderate Interactions (Monitor Closely): - Combination with anti‑inflammatory eye drops: may heighten stinging sensation. - Use alongside systemic antihistamines: may exacerbate dry eye symptoms. - Co‑administration with contact lens cleaning solutions: could diminish lubricating effect. - Simultaneous use with mydriatic agents: may affect pupil response. - Application with ocular anesthetics: may increase corneal sensitivity.